Literature DB >> 32367699

Can Complete Blood Count Parameters Predict Retinopathy of Prematurity?

Ayşe İpek Akyüz Ünsal1, Özge Key1, Duygu Güler1, İmran Kurt Omurlu2, Ayşe Anık3, Buket Demirci4, Sema Dündar1.   

Abstract

Objectives: To predict the risk of retinopathy of prematurity (ROP) development according to routine complete blood count (CBC) parameters. Materials and
Methods: The medical records and CBC results of 150 premature neonates were retrospectively evaluated. As ROP develops 1 month after birth, first month CBC profiles of neonates without ROP (non-ROP), with ROP (ROP group), and those with Type 1, Type 2, and Stage 1+2 ROP were compared. Besides known statistical methods like Student's t-test, logistic regression and classification & regression tree (C&RT) analysis were also done to identify a reliable quantitative predictive parameter.
Results: Mean gestational age and birth weight of the ROP group (n=99) and non-ROP (n=43) group were 29.39±3.43 and 32.05±2.20 weeks and 1382.44±545.30 and 1691.51±360.84 grams, respectively (p<0.001, p<0.001). Average hemoglobin (Hb) (p<0.001), hematocrit (HCT) (p<0.001), erythrocyte (p=0.005), mean corpuscular hemoglobin (MCH) (p=0.020), and MCH concentration (p=0.019) values of the ROP group were lower than those of the non-ROP group. Leukocyte was higher in the ROP group (p=0.018). Hb [odds ratio (OR)=0.668, 95% confidence interval (CI)=0.555-0.804, p<0.001], red cell distribution width (RDW) (OR=1.282, 95% CI=1.012-1.624, p=0.040), leukocyte (OR=1.157, 95% CI=1.053-1.271, p=0.002), and platelet (OR=0.997, 95% CI: 0.994-0.999, p=0.036) values differed significantly between the two groups. Platelet, MCV, and MCH parameters were found to be lower in the Type 1 ROP group compared to the Stage 1+2 ROP group (p<0.005). MCH was the most prominent predictor (cut-off: 34.43 pg) according to the results of C&RT analysis.
Conclusion: As Hb plays an important role in oxygen transport, low levels of Hb and especially MCH may cause increased vascular endothelial growth factor secretion from the hypoxic retina, thereby causing ROP. Therefore, the results of this study are encouraging regarding the use of the abovementioned CBC parameters as a simple screening test to predict ROP.

Entities:  

Keywords:  Retinopathy of prematurity; complete blood count; risk prediction

Year:  2020        PMID: 32367699      PMCID: PMC7204894          DOI: 10.4274/tjo.galenos.2019.45313

Source DB:  PubMed          Journal:  Turk J Ophthalmol        ISSN: 2149-8709


  18 in total

Review 1.  Reference Intervals in Neonatal Hematology.

Authors:  Erick Henry; Robert D Christensen
Journal:  Clin Perinatol       Date:  2015-05-13       Impact factor: 3.430

Review 2.  The International Classification of Retinopathy of Prematurity revisited.

Authors: 
Journal:  Arch Ophthalmol       Date:  2005-07

Review 3.  Retinopathy of prematurity-incidence today.

Authors:  Andrea Zin; Glen A Gole
Journal:  Clin Perinatol       Date:  2013-06       Impact factor: 3.430

4.  Relationship between mean platelet volume and retinopathy of prematurity.

Authors:  Yuan Tao; Yu Dong; Cheng-Wei Lu; Wei Yang; Qian Li
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-03-08       Impact factor: 3.117

5.  Role of hematological parameters in predicting retinopathy of prematurity (ROP) in preterm neonates.

Authors:  H S Niranjan; K R Bharath Kumar Reddy; Naveen Benakappa; Krishna Murthy; Shivananda Shivananda; Vishwanath Veeranna
Journal:  Indian J Pediatr       Date:  2013-02-23       Impact factor: 1.967

6.  Nucleated red blood cells in preterm infants with retinopathy of prematurity.

Authors:  Ronit Lubetzky; Chaim Stolovitch; Shaul Dollberg; Francis B Mimouni; Mazal Salomon; Dror Mandel
Journal:  Pediatrics       Date:  2005-09-30       Impact factor: 7.124

7.  Hypoxia accelerates nitric oxide-dependent inhibition of mitochondrial complex I in activated macrophages.

Authors:  Matthew T Frost; Qi Wang; Salvador Moncada; Mervyn Singer
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2004-10-14       Impact factor: 3.619

8.  Serum neutrophil-to-lymphocyte ratio in retinopathy of prematurity.

Authors:  Bengi Ece Kurtul; Emrah Utku Kabatas; Aysegul Zenciroglu; Pinar Altiaylik Ozer; Gokce Tasdemir Ertugrul; Serdar Beken; Nurullah Okumus
Journal:  J AAPOS       Date:  2015-07-31       Impact factor: 1.220

Review 9.  Hemoglobin α in the blood vessel wall.

Authors:  Joshua T Butcher; Tyler Johnson; Jody Beers; Linda Columbus; Brant E Isakson
Journal:  Free Radic Biol Med       Date:  2014-05-14       Impact factor: 7.376

10.  Incidence and risk factors for retinopathy of prematurity in multiple gestations: a Chinese population study.

Authors:  Gordon S K Yau; Jacky W Y Lee; Victor T Y Tam; Stan Yip; Edith Cheng; Catherine C L Liu; Benjamin C Y Chu; Ian Y H Wong
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

View more
  5 in total

1.  The Role of Thrombocyte Parameters in Retinopathy of Prematurity Development.

Authors:  Dilek Özkaya
Journal:  Int J Clin Pract       Date:  2022-01-31       Impact factor: 3.149

Review 2.  Novel Potential Biomarkers for Retinopathy of Prematurity.

Authors:  Wei Tan; Bingyan Li; Zicong Wang; Jingling Zou; Yang Jia; Shigeo Yoshida; Yedi Zhou
Journal:  Front Med (Lausanne)       Date:  2022-02-02

3.  Clinical parameters in different stages, zones, and remission/progression statuses of retinopathy of prematurity.

Authors:  Seyed Ahmad Rasoulinejad; Faezeh Maroufi; Ahad Alizadeh
Journal:  Caspian J Intern Med       Date:  2022

4.  Haemoglobin Levels in Early Life among Infants with and without Retinopathy of Prematurity.

Authors:  Edwin Pheng; Zi Di Lim; Evelyn Tai Li Min; Hans Van Rostenberghe; Ismail Shatriah
Journal:  Int J Environ Res Public Health       Date:  2021-07-01       Impact factor: 3.390

5.  Commentary: Predicting need for treatment in retinopathy of prematurity - The elusive Holy Grail.

Authors:  Manavi D Sindal
Journal:  Indian J Ophthalmol       Date:  2022-04       Impact factor: 2.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.